fisaerh1的部落格

A patentable innovation is an conception that is "novel" underneath 35 U.S.C.A. § 102, "useful" beneath 35 U.S.C.A. § 101, and "nonobvious" beneath 35 U.S.C.A. § 103. Section 103(a) of the Patent Act sets off the parametric quantity of the patency requirement:

A patent may not be obtained although the creative thinking is not identically disclosed or represented as set off in Section 102 of this title, if the differences involving the subject matter thing wanted to be patented and the prior art must not be such as that the topic issue as a unharmed would have been obvious at the circumstance the design was ready-made to a causal agency having mediocre ingenuity in the art to which said premise substance pertains.

In Graham v. John Deere Co., 383 U.S. 1, 17 (1966), the United States Supreme Court taken this terminology to tight that the classic willpower on the feature of noticeableness is burned as a put somebody through the mill of law but is based on factual inquires that count (1) the breadth and smug of the prior art; (2) the differences betwixt the preceding art and the claimed invention; (3) the horizontal of attainment in the art; and (4) the target documentation of non-obviousness.

To get your hands on a patent on a new chemic compound, the bipinnate must meet the nonobviousness responsibility at the occurrence it is made-up. Special issues, however, develop next to chemical patents because unalike physical phenomenon and mechanised sciences, natural science is an up and down art. Minor changes in structures can dramatically affect a compound's properties. Thus, it is inherently embarrassing for a committee to ascertain the noticeability of a claimed dissected with a analogous construction to that of a anterior art.

The point of the confront to discover the conspicuousness of chemic compounds can be illustrated by the issues moon-faced by the assembly in Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, 231 F.3d 1339 (Fed. Cir. 2000). In Yamanouchi, the quarrel centered on whether one skilful in the art would have reasoned it frank to make the pills Famotidine by (1) combining the charged tail from metal even-pinnate 44 beside the made to order heterocycle from Tiotidine to be an in-between compound, and (2) subbing the carbamoyl sort in the mediate combined beside a sulfamoyl set to concoct Famotidine as shown downwards in Scheme 1. It was ably legendary that some Tiotidine and Tagamet were prior compounds, of which Tagamet was a winning remedy in market situate spell Tiotidine bungled in diagnosing trials due to its full definite quantity. Both compounds, however, showed great effectivity as inhibitors of gastric acerbic secernment.

The judicature in Yamanouchi upheld the rights against an affirmation of conspicuousness. Id. at 1345. The judicature explained, "For a chemic compound, a starring facie proceedings of patency requires a showing of 'structural equality between claimed and antecedent art thesis matter ... wherever the antecedent art gives drive or motivation to sort the claimed compositions.'" Id. at 1343 (quoting In re Dillon, 919 F.3d 688, 692 (Fed. Cir. 1990)). Even but the claimed bilobate substandard the check of noesis similarity, the Yamanouchi panel nullified a star facie travel case of conspicuousness supported on a want of psychological feature to combine the prior art to trade name the claimed excogitation near analogous birth mathematical function to that of the prior art.

A. Structural similarity

Structural analogy relating chemic compounds has efficaciously created a characteristic and troublesome region of unobstructed law. In re Jones, 958 F.2d 347, 350 (Fed. Cir. 1992). In determinative the noticeability of a traditional chemical compound, courts in the past decided on the identicalness linking the structures of a claimed bipinnate and that of a bilobed unveiled in the anterior art. In re Hass, 141 F.2d 122 (C.C.P.A 1944); In re Henze, 181 F.2d 196 (C.C.P.A. 1950).

In Hass, the claimed pinnated was a homolog of a preceding art bipinnatifid (Scheme 2). See Hass, 141 F.2d at 125. There was single one more chemical element definite quantity in the claimed lobed than that in the anterior art. The Court of Claims and Patent Appeals control that the claimed multiple was not patentable unless it unconcealed "some nonobvious or unforeseen valuable properties not possessed by the homologous abruptly-pinnate disclosed in the preceding art." Id. The pandemic ideology down the court's verdict was that chemic and physiologic properties alter individual a tad betwixt members of a homologous string. Id. The Henze overnight case changed this view into a precondition that was rebuttable if the individual showed "that the claimed trilobate possesses unapparent or sudden advantageous properties not in actual fact obsessed by the preceding art homologues." In re Henze, 181 F.2d at 201. Clearly some courts detected chemic framework and natural science properties as two contrastive considerations. Therefore, for structurally quasi natural science homologues, a new smooth was deemed star facie manifest because a scientist could look forward to or forebode that the new chemical bilobated would have the aforesaid properties in a fixed grouping as did a correspondent preceding art bipinnate.

B. Inseparable construction and its properties

After passage 103 was enacted, courts unhurriedly touched to a more holistic estimation of natural science compounds that thoughtful chemical properties in enhancement to chemical structures. In re Papesch, 315 F.2d 381 (C.C.P.A. 1971). In ­Papesch, an petitioner claimed a ethnic group of compounds plus representative combination 2,4,6-triethylpyrazolo(4,3-d)-4,5,6,7-tetrahydropyrimidine-5,7-dione (ethyl = CH2CH3), which was confessedly "structurally obvious" in muted of a claimed pinnated 2,4,6-trimethylpyrazolo(4,3-d)-4,5,6.7-tetrahydropyrimidine-5,7-dione (methyl = CH3) as shown in Scheme 3. Id. at 384.

Comparative tests of the trimethyl amalgamated and the applicant's triethyl tripinnatifid showed that the latter was an influential medication cause piece the anterior art paripinnate was smarmy redundant for that utility. The Papesch hearing stated that the properties of compounds were applicable to obviousness, emphasizing that the conception as a livelong was a bilobed near its own properties. Id. at 390. Additionally, the assembly found that proof of non-obvious or out of the blue discriminatory properties not shared by the anterior art trifoliolate may renounce a leading facie crust of noticeability. Id. at 391.

A trilobed and all of its properties are inseparable; they are one and the same state of affairs .... But a expression is not a ternate and while it may service in a assertion to individuality what is being patented, as the metes and boundary of a work identify a secret plan of land, the article that is patented is not the mathematical statement but the complex known by it. And the patentability of the item does not be on the similarity of its expression to that of other compound but of the resemblance of the one-time palmatifid to the latter. There is no spring in law for ignoring any geographic region in devising such a examination. Id.

Thus the court amply pressed natural science government grant applications as eternal as a claimed conception could present new properties even still the claimed cleft collective a similar artefact with a anterior art trilobate. The Papesch court, however, did not operate beside the requirements for establishing a prima facie proceedings of patency. The judicature sole control that, for cases near a given of obviousness, an querier had to think both the properties of the excogitation and the knowledge correlation. Id.